MACCURA BIOTECHNOLOGY CO.LTD Maccura Biotechnology Co.Ltd Stock
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.9 CNY | +0.87% |
|
+5.78% | -7.76% |
| Apr. 25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
| Apr. 24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 3.1B 429M | Sales 2025 * | 3.48B 482M | Capitalization | 8.43B 1.17B |
|---|---|---|---|---|---|
| Net income 2024 * | 444M 61.46M | Net income 2025 * | 591M 81.81M | EV / Sales 2024 * | 2.72 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.42 x |
| P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
14.4
x | Employees | 3,362 |
| Yield 2024 * |
2.01% | Yield 2025 * |
3.02% | Free-Float | 61.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.87% | ||
| 1 week | +5.78% | ||
| Current month | +5.78% | ||
| 1 month | +7.92% | ||
| 3 months | +10.76% | ||
| 6 months | -11.46% | ||
| Current year | -7.76% |
1 week
13.30
14.00
1 month
11.4014.00
Current year
9.9015.23
1 year
9.9017.40
3 years
9.9049.34
5 years
9.9065.24
10 years
9.9065.24
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Jian Wu
CEO | Chief Executive Officer | 49 | 01-12-31 |
Shan Yin
DFI | Director of Finance/CFO | 44 | 21-10-25 |
Yong Tang
CHM | Chairman | 60 | 94-10-19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dai Guo Fu
BRD | Director/Board Member | 60 | 19-01-21 |
Yong Tang
CHM | Chairman | 60 | 94-10-19 |
Qi Lin Liu
BRD | Director/Board Member | 58 | 93-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 13.9 | +0.87% | 6,085,005 |
| 24-05-08 | 13.78 | +0.15% | 7,434,600 |
| 24-05-07 | 13.76 | +1.03% | 7,678,843 |
| 24-05-06 | 13.62 | +3.65% | 9,524,939 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotes
Maccura Biotechnology Co., Ltd., formerly Sichuan Maccura Biotechnology Co., Ltd., is a China-based company principally engaged in research, development, manufacture and sales of in-vitro diagnostics products and the sales of in-vitro diagnostic products of foreign brands as an agent. The Company provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.9
CNY
Average target price
15.46
CNY
Spread / Average Target
+11.22%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.76% | 1.17B | |
| +0.20% | 12.64B | |
| -1.64% | 8.37B | |
| +0.43% | 5.37B | |
| +22.42% | 5.26B | |
| -0.09% | 4.58B | |
| -52.84% | 3.16B | |
| +20.02% | 2.89B | |
| -8.37% | 2.22B | |
| -2.45% | 1.91B |
- Stock Market
- Equities
- 300463 Stock